Tiffany Oates
Primary Care · Glen Rose, TXNPI 1255884920
Payments from drug & device makers
Across 90 payments — averaging $24.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$549
- Amgen$410
- Sumitomo Pharma America, Inc.$184
- Novo Nordisk$169
- Lilly USA, LLC$161
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$160
- plus $575 from 17 others
What the payments were for
- Food & beverage$2,208100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 23 | $549 |
| Amgen | 12 | $410 |
| Sumitomo Pharma America, Inc. | 10 | $184 |
| Novo Nordisk | 10 | $169 |
| Lilly USA, LLC | 3 | $161 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $160 |
| Dexcom, Inc. | 1 | $119 |
| Otsuka America Pharmaceutical, Inc. | 4 | $71 |
| AstraZeneca | 3 | $60 |
| Axsome Therapeutics, Inc. | 3 | $48 |
| Bayer | 3 | $46 |
| GSK | 2 | $32 |
| Idorsia Pharmaceuticals US Inc | 2 | $29 |
| Lundbeck LLC | 1 | $23 |
| IBSA Pharma Inc. | 1 | $20 |
| Merck | 1 | $20 |
| Pfizer | 1 | $19 |
| Abbott | 1 | $18 |
| Exact Sciences | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Biogen | 1 | $12 |
| Currax Pharmaceuticals LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EVENITY$130
- MOUNJARO$125
- AIMOVIG$123
- DEXCOM G7 GSS (161)$119
- CAPLYTA$110
How this compares
$2,208 in reported general payments places this provider in the 85th percentile of 563 primary care providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 18 | $24,249 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 18 | $11,945 |
| XareltoRivaroxaban | 15 | $11,539 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 66 | $1,594 |
| SynthroidLevothyroxine Sodium | 13 | $1,154 |
| ProgesteroneProgesterone, Micronized | 11 | $1,062 |
| Levothyroxine Sodium | 54 | $651 |
| Atorvastatin Calcium | 56 | $547 |
| Gabapentin | 42 | $533 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 56 | $489 |
| Bupropion XlBupropion Hcl | 23 | $486 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 32 | $456 |
| Rosuvastatin Calcium | 20 | $450 |
| Nystatin | 19 | $428 |
| Amlodipine Besylate-BenazeprilAmlodipine Besylate/Benazepril | 11 | $404 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $169 | $24,24918 claims |
| GSKTrelegy Ellipta | $32 | $11,94518 claims |
| AbbVieSynthroid | $549 | $1,15413 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 563 primary care providers in Texas.
Other primary care in Glen Rose
- Mary GibbensHouston$42K
- Phillip GulleySan Antonio$23K
- Herbert BautistaDallas$14K
- Roxana RoposGrapevine$13K
- Brandi JoynerLongview$12K
- Steven ParisAustin$10K
- Hope OdomCollege Station$10K
- Arlena GraysTomball$9K
- Charlotte BallardSan Antonio$9K
- Hannah LancasterMcKinney$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.